Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Anatomical Variations of the Left Renal Vein During Laparoscopic Donor Nephrectomy.

Tatarano S, Enokida H, Yamada Y, Nishimura H, Yoshino H, Ishihara T, Yonemori M, Eura R, Sakaguchi T, Nakagawa M.

Transplant Proc. 2019 Jun;51(5):1311-1313. doi: 10.1016/j.transproceed.2019.01.132. Epub 2019 Apr 26.

PMID:
31036354
2.

Tumor‑suppressive microRNA‑223 targets WDR62 directly in bladder cancer.

Sugita S, Yoshino H, Yonemori M, Miyamoto K, Matsushita R, Sakaguchi T, Itesako T, Tatarano S, Nakagawa M, Enokida H.

Int J Oncol. 2019 Jun;54(6):2222-2236. doi: 10.3892/ijo.2019.4762. Epub 2019 Mar 22.

PMID:
30942440
3.

Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2.

Osako Y, Yoshino H, Sakaguchi T, Sugita S, Yonemori M, Nakagawa M, Enokida H.

Int J Oncol. 2019 May;54(5):1759-1770. doi: 10.3892/ijo.2019.4736. Epub 2019 Feb 28.

PMID:
30816432
4.

Living Kidney Donor With Small Lymphocytic Lymphoma at the Time of Donation: A Case Report.

Tatarano S, Enokida H, Yamada Y, Nishimura H, Nakagawa M.

Transplant Proc. 2018 Oct;50(8):2581-2582. doi: 10.1016/j.transproceed.2018.04.016. Epub 2018 Apr 11.

PMID:
30316403
5.

Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.

Nishimura H, Yamada Y, Hisano S, Mitsuke A, Tatarano S, Gotanda T, Hayami H, Nakagawa M, Enokida H.

BMC Nephrol. 2018 Oct 5;19(1):254. doi: 10.1186/s12882-018-1053-8.

6.

Oral Propranolol in a Child With Infantile Hemangioma of the Urethra.

Itesako T, Eura R, Okamoto Y, Tatarano S, Yoshino H, Nishimura H, Yamada Y, Enokida H, Nakagawa M.

Urology. 2018 Dec;122:165-168. doi: 10.1016/j.urology.2018.06.002. Epub 2018 Jun 14.

PMID:
29908866
7.

HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.

Sugita S, Enokida H, Yoshino H, Miyamoto K, Yonemori M, Sakaguchi T, Osako Y, Nakagawa M.

Int J Oncol. 2018 Aug;53(2):725-736. doi: 10.3892/ijo.2018.4435. Epub 2018 Jun 11.

PMID:
29901113
8.

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.

Sakaguchi T, Yoshino H, Sugita S, Miyamoto K, Yonemori M, Osako Y, Meguro-Horike M, Horike SI, Nakagawa M, Enokida H.

Oncotarget. 2018 May 1;9(33):23003-23017. doi: 10.18632/oncotarget.25190. eCollection 2018 May 1.

9.

Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.

Nishimura H, Enokida H, Sakamoto T, Takahashi T, Hayami H, Nakagawa M.

J Artif Organs. 2018 Sep;21(3):378-382. doi: 10.1007/s10047-018-1044-3. Epub 2018 Apr 19.

PMID:
29675599
10.

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.

Sakaguchi T, Yoshino H, Yonemori M, Miyamoto K, Sugita S, Matsushita R, Itesako T, Tatarano S, Nakagawa M, Enokida H.

Br J Cancer. 2018 Mar 20;118(6):e7. doi: 10.1038/bjc.2017.439. Epub 2018 Feb 13.

11.

Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.

Yoshino H, Yonezawa T, Yonemori M, Miyamoto K, Sakaguchi T, Sugita S, Osako Y, Tatarano S, Nakagawa M, Enokida H.

Oncol Rep. 2018 Jan;39(1):173-181. doi: 10.3892/or.2017.6098. Epub 2017 Nov 15.

PMID:
29192325
12.

Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.

Izumi K, Mizokami A, Namiki M, Inoue S, Tanaka N, Yoshio Y, Ishibashi K, Kamiyama M, Kawai N, Enokida H, Shima T, Takahara S.

BMC Cancer. 2017 Oct 10;17(1):677. doi: 10.1186/s12885-017-3661-2.

13.

PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.

Yoshino H, Nohata N, Miyamoto K, Yonemori M, Sakaguchi T, Sugita S, Itesako T, Kofuji S, Nakagawa M, Dahiya R, Enokida H.

Cancer Res. 2017 Nov 15;77(22):6321-6329. doi: 10.1158/0008-5472.CAN-17-1589. Epub 2017 Sep 26.

14.

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.

Sakaguchi T, Yoshino H, Yonemori M, Miyamoto K, Sugita S, Matsushita R, Itesako T, Tatarano S, Nakagawa M, Enokida H.

Br J Cancer. 2017 Apr 11;116(8):1077-1087. doi: 10.1038/bjc.2017.43. Epub 2017 Mar 21. Erratum in: Br J Cancer. 2018 Feb 13;:.

15.

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.

Yoshino H, Yonemori M, Miyamoto K, Tatarano S, Kofuji S, Nohata N, Nakagawa M, Enokida H.

Oncotarget. 2017 Mar 28;8(13):20881-20894. doi: 10.18632/oncotarget.14930.

16.

Is It Safe to Use the Same Scissors After Accidental Tumor Incision During Partial Nephrectomy? Results of In Vitro and In Vivo Experiments.

Yoshino H, Miyamoto K, Hwang EC, Yamane T, Nakagawa M, Enokida H.

J Endourol. 2017 Apr;31(4):391-395. doi: 10.1089/end.2016.0848. Epub 2017 Jan 25.

PMID:
28049342
17.

Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.

Yonemori M, Seki N, Yoshino H, Matsushita R, Miyamoto K, Nakagawa M, Enokida H.

Cancer Sci. 2016 Sep;107(9):1233-42. doi: 10.1111/cas.13002. Epub 2016 Sep 6.

18.

[Retropubic radical prostatectomy].

Enokida H, Nakagawa M.

Nihon Rinsho. 2016 May 20;74 Suppl 3:421-6. Japanese. No abstract available.

PMID:
27344768
19.

The role of microRNAs in bladder cancer.

Enokida H, Yoshino H, Matsushita R, Nakagawa M.

Investig Clin Urol. 2016 Jun;57 Suppl 1:S60-76. doi: 10.4111/icu.2016.57.S1.S60. Epub 2016 Jun 7. Review.

20.

Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.

Miyamoto K, Seki N, Matsushita R, Yonemori M, Yoshino H, Nakagawa M, Enokida H.

Br J Cancer. 2016 Jul 26;115(3):354-63. doi: 10.1038/bjc.2016.179. Epub 2016 Jun 16.

21.

Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.

Matsushita R, Yoshino H, Enokida H, Goto Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M, Seki N.

Oncotarget. 2016 May 10;7(19):28460-87. doi: 10.18632/oncotarget.8668.

22.

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.

Low SK, Fukunaga K, Takahashi A, Matsuda K, Hongo F, Nakanishi H, Kitamura H, Inoue T, Kato Y, Tomita Y, Fukasawa S, Tanaka T, Nishimura K, Uemura H, Hara I, Fujisawa M, Matsuyama H, Hashine K, Tatsugami K, Enokida H, Kubo M, Miki T, Mushiroda T.

PLoS One. 2016 Feb 25;11(2):e0148177. doi: 10.1371/journal.pone.0148177. eCollection 2016.

23.

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.

Mizuno K, Seki N, Mataki H, Matsushita R, Kamikawaji K, Kumamoto T, Takagi K, Goto Y, Nishikawa R, Kato M, Enokida H, Nakagawa M, Inoue H.

Int J Oncol. 2016 Feb;48(2):450-60. doi: 10.3892/ijo.2015.3289. Epub 2015 Dec 14.

24.

Acute Kidney Injury and Rhabdomyolysis After Protobothrops flavoviridis Bite: A Retrospective Survey of 86 Patients in a Tertiary Care Center.

Nishimura H, Enokida H, Kawahira S, Kagara I, Hayami H, Nakagawa M.

Am J Trop Med Hyg. 2016 Feb;94(2):474-9. doi: 10.4269/ajtmh.15-0549. Epub 2015 Dec 7.

25.

Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.

Kurozumi A, Goto Y, Matsushita R, Fukumoto I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Cancer Sci. 2016 Jan;107(1):84-94. doi: 10.1111/cas.12842. Epub 2015 Dec 5.

26.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Fukumoto I, Kikkawa N, Matsushita R, Kato M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2016 Feb;61(2):109-18. doi: 10.1038/jhg.2015.120. Epub 2015 Oct 22.

PMID:
26490187
27.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.

Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2015 Sep 29;113(7):1055-65. doi: 10.1038/bjc.2015.300. Epub 2015 Sep 1.

28.

Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Nishikawa R, Chiyomaru T, Enokida H, Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa M, Seki N.

FEBS Lett. 2015 Jul 22;589(16):2136-45. doi: 10.1016/j.febslet.2015.06.005. Epub 2015 Jun 19.

29.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Int J Oncol. 2015 Aug;47(2):710-8. doi: 10.3892/ijo.2015.3043. Epub 2015 Jun 10.

PMID:
26063484
30.

MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.

Nishikawa R, Goto Y, Kurozumi A, Matsushita R, Enokida H, Kojima S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

Int J Urol. 2015 Sep;22(9):867-77. doi: 10.1111/iju.12829. Epub 2015 Jun 7.

31.

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.

Matsushita R, Seki N, Chiyomaru T, Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S, Itesako T, Nakagawa M, Enokida H.

Br J Cancer. 2015 Jul 14;113(2):282-9. doi: 10.1038/bjc.2015.195. Epub 2015 Jun 9.

32.

The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.

Yamamoto N, Nishikawa R, Chiyomaru T, Goto Y, Fukumoto I, Usui H, Mitsuhashi A, Enokida H, Nakagawa M, Shozu M, Seki N.

Int J Oncol. 2015 Jul;47(1):325-34. doi: 10.3892/ijo.2015.2986. Epub 2015 May 5.

PMID:
25955017
33.

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.

Fukumoto I, Hanazawa T, Kinoshita T, Kikkawa N, Koshizuka K, Goto Y, Nishikawa R, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Br J Cancer. 2015 Mar 3;112(5):891-900. doi: 10.1038/bjc.2015.19. Epub 2015 Feb 10.

34.

Functional significance of aberrantly expressed microRNAs in prostate cancer.

Goto Y, Kurozumi A, Enokida H, Ichikawa T, Seki N.

Int J Urol. 2015 Mar;22(3):242-52. doi: 10.1111/iju.12700. Epub 2015 Jan 20. Review.

35.

Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.

Mataki H, Seki N, Chiyomaru T, Enokida H, Goto Y, Kumamoto T, Machida K, Mizuno K, Nakagawa M, Inoue H.

Int J Oncol. 2015 Mar;46(3):1039-50. doi: 10.3892/ijo.2014.2802. Epub 2014 Dec 18.

PMID:
25522678
36.

Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C.

Mataki H, Enokida H, Chiyomaru T, Mizuno K, Matsushita R, Goto Y, Nishikawa R, Higashimoto I, Samukawa T, Nakagawa M, Inoue H, Seki N.

J Hum Genet. 2015 Feb;60(2):53-61. doi: 10.1038/jhg.2014.111. Epub 2014 Dec 18.

PMID:
25518741
37.

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.

Chiyomaru T, Seki N, Inoguchi S, Ishihara T, Mataki H, Matsushita R, Goto Y, Nishikawa R, Tatarano S, Itesako T, Nakagawa M, Enokida H.

Int J Oncol. 2015 Feb;46(2):487-96. doi: 10.3892/ijo.2014.2752. Epub 2014 Nov 14.

38.

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.

Goto Y, Kojima S, Nishikawa R, Enokida H, Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Oncotarget. 2014 Sep 15;5(17):7748-59.

39.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Tumour Biol. 2014 Oct;35(10):10223-30. doi: 10.1007/s13277-014-2292-3. Epub 2014 Jul 17.

PMID:
25027399
40.

Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma.

Ishihara T, Seki N, Inoguchi S, Yoshino H, Tatarano S, Yamada Y, Itesako T, Goto Y, Nishikawa R, Nakagawa M, Enokida H.

J Urol. 2014 Dec;192(6):1822-30. doi: 10.1016/j.juro.2014.07.001. Epub 2014 Jul 9.

PMID:
25014580
41.

Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.

Inoguchi S, Seki N, Chiyomaru T, Ishihara T, Matsushita R, Mataki H, Itesako T, Tatarano S, Yoshino H, Goto Y, Nishikawa R, Nakagawa M, Enokida H.

FEBS Lett. 2014 Aug 25;588(17):3170-9. doi: 10.1016/j.febslet.2014.06.058. Epub 2014 Jul 3.

42.

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.

Fukumoto I, Kinoshita T, Hanazawa T, Kikkawa N, Chiyomaru T, Enokida H, Yamamoto N, Goto Y, Nishikawa R, Nakagawa M, Okamoto Y, Seki N.

Br J Cancer. 2014 Jul 15;111(2):386-94. doi: 10.1038/bjc.2014.293. Epub 2014 Jun 10.

43.

Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.

Nishikawa R, Goto Y, Kojima S, Enokida H, Chiyomaru T, Kinoshita T, Sakamoto S, Fuse M, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2014 Jul;45(1):401-10. doi: 10.3892/ijo.2014.2437. Epub 2014 May 9.

PMID:
24820027
44.

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

Nishikawa R, Goto Y, Sakamoto S, Chiyomaru T, Enokida H, Kojima S, Kinoshita T, Yamamoto N, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2014 Jul;105(7):802-11. doi: 10.1111/cas.12441. Epub 2014 Jun 18.

45.

Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.

Goto Y, Nishikawa R, Kojima S, Chiyomaru T, Enokida H, Inoguchi S, Kinoshita T, Fuse M, Sakamoto S, Nakagawa M, Naya Y, Ichikawa T, Seki N.

FEBS Lett. 2014 May 21;588(10):1973-82. doi: 10.1016/j.febslet.2014.04.020. Epub 2014 Apr 24.

46.

microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.

Kikkawa N, Kinoshita T, Nohata N, Hanazawa T, Yamamoto N, Fukumoto I, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Int J Oncol. 2014 Jun;44(6):2085-92. doi: 10.3892/ijo.2014.2349. Epub 2014 Mar 19.

PMID:
24647829
47.

Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, Dahiya R, Yamamura S.

J Biol Chem. 2014 May 2;289(18):12550-65. doi: 10.1074/jbc.M113.488593. Epub 2014 Mar 10.

48.

The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.

Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.

PLoS One. 2014 Feb 10;9(2):e84311. doi: 10.1371/journal.pone.0084311. eCollection 2014.

49.

The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.

Kojima S, Enokida H, Yoshino H, Itesako T, Chiyomaru T, Kinoshita T, Fuse M, Nishikawa R, Goto Y, Naya Y, Nakagawa M, Seki N.

J Hum Genet. 2014 Feb;59(2):78-87. doi: 10.1038/jhg.2013.121. Epub 2013 Nov 28.

PMID:
24284362
50.

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.

Yamamoto N, Kinoshita T, Nohata N, Yoshino H, Itesako T, Fujimura L, Mitsuhashi A, Usui H, Enokida H, Nakagawa M, Shozu M, Seki N.

Int J Oncol. 2013 Dec;43(6):1855-63. doi: 10.3892/ijo.2013.2145. Epub 2013 Oct 18.

Supplemental Content

Loading ...
Support Center